Eris: Symptoms, Vaccines and all about the new dominant Covid variant which is leading to a fresh wave in the U.S and U.K
This renewed caution is due to the emergence of two new variants: Omicron EG.5 (Eris), predominant in the US, and the spreading BA.2.86 variant. The World Health Organization (WHO) classifies EG.5 as a «variant of interest» as cases increase worldwide.
While EG.5 doesn't appear substantially more dangerous than other variants, health officials remain vigilant. The situation underscores the importance of vaccination, mask-wearing, and adherence to public health guidelines, particularly among vulnerable populations.
Prevalence in the United States
Eris has rapidly gained notoriety as it currently accounts for approximately 17% of new Covid-19 cases in the United States. Its swift ascent to prominence marks a significant development in the ongoing battle against the coronavirus.
A Descendant of Omicron
This variant is a direct descendant of the Omicron variant, which previously made headlines for its heightened transmissibility. Eris has inherited some of these traits, making it a formidable player in the world of Covid-19 variants.
A Dominant Force
Eris has solidified its dominance not only in the United States but also in the United Kingdom. Its rapid spread underscores the need for vigilance and research in tracking and understanding its behavior.
Symptoms
EG.5, commonly known as Eris, does not exhibit enhanced contagiousness, severe symptoms, or a heightened likelihood of causing severe illness. Diagnostic tests and treatments, such as Paxlovid, continue to effectively manage it, according to experts like Dr. Andrew Pekosz, a professor at Johns Hopkins University Bloomberg School of Public Health. While concerns about EG.5 exist, it does not pose a substantially greater threat than other current variants.
However, some
